Näytä suppeat kuvailutiedot

Type 2 diabetes enhances arterial uptake of choline in atherosclerotic mice: an imaging study with positron emission tomography tracer F-18-fluoromethylcholine

Kiugel M; Yla-Herttuala S; Nuutila P; Metso J; Saukko P; Metsala O; Saraste A; Silvola JMU; Liljenback H; Viljanen T; Roivainen A; Knuuti J; Jauhiainen M; Hellberg S

dc.contributor.authorKiugel M
dc.contributor.authorYla-Herttuala S
dc.contributor.authorNuutila P
dc.contributor.authorMetso J
dc.contributor.authorSaukko P
dc.contributor.authorMetsala O
dc.contributor.authorSaraste A
dc.contributor.authorSilvola JMU
dc.contributor.authorLiljenback H
dc.contributor.authorViljanen T
dc.contributor.authorRoivainen A
dc.contributor.authorKnuuti J
dc.contributor.authorJauhiainen M
dc.contributor.authorHellberg S
dc.date.accessioned2022-10-27T11:57:25Z
dc.date.available2022-10-27T11:57:25Z
dc.identifier.urihttps://www.utupub.fi/handle/10024/156184
dc.description.abstract<p><b>Background: </b>Diabetes is a risk factor for atherosclerosis associated with oxidative stress, inflammation and cell proliferation. The purpose of this study was to evaluate arterial choline uptake and its relationship to atherosclerotic inflammation in diabetic and non-diabetic hypercholesterolemic mice.<b><br /></b><b>Methods: </b>Low-density lipoprotein-receptor deficient mice expressing only apolipoprotein B100, with or without type 2 diabetes caused by pancreatic overexpression of insulin-like growth factor II (IGF-II/LDLR<sup>−/−</sup>ApoB<sup>100/100</sup> and LDLR<sup>−/−</sup>ApoB<sup>100/100</sup>) were studied. Distribution kinetics of choline analogue <sup>18</sup>F-fluoromethylcholine (<sup>18</sup>F-FMCH) was assessed in vivo by positron emission tomography (PET) imaging. Then, aortic uptakes of <sup>18</sup>F-FMCH and glucose analogue <sup>18</sup>F-fluorodeoxyglucose (<sup>18</sup>F-FDG), were assessed ex vivo by gamma counting and autoradiography of tissue sections. The <sup>18</sup>F-FMCH uptake in atherosclerotic plaques was further compared with macrophage infiltration and the plasma levels of cytokines and metabolic markers. <br /><b>Results: </b>The aortas of all hypercholesterolemic mice showed large, macrophage-rich atherosclerotic plaques. The plaque burden and densities of macrophage subtypes were similar in diabetic and non-diabetic animals. The blood clearance of <sup>18</sup>F-FMCH was rapid. Both the absolute <sup>18</sup>F-FMCH uptake in the aorta and the aorta-to-blood uptake ratio were higher in diabetic than in non-diabetic mice. In autoradiography, the highest <sup>18</sup>F-FMCH uptake co-localized with macrophage-rich atherosclerotic plaques. <sup>18</sup>F-FMCH uptake in plaques correlated with levels of total cholesterol, insulin, C-peptide and leptin. In comparison with <sup>18</sup>F-FDG, <sup>18</sup>F-FMCH provided similar or higher plaque-to-background ratios in diabetic mice. <br /><b>Conclusions: </b>Type 2 diabetes enhances the uptake of choline that reflects inflammation in atherosclerotic plaques in mice. PET tracer <sup>18</sup>F-FMCH is a potential tool to study vascular inflammation associated with diabetes.</p>
dc.language.isoen
dc.publisherBIOMED CENTRAL LTD
dc.titleType 2 diabetes enhances arterial uptake of choline in atherosclerotic mice: an imaging study with positron emission tomography tracer F-18-fluoromethylcholine
dc.identifier.urnURN:NBN:fi-fe2021042715257
dc.relation.volume15
dc.contributor.organizationfi=PET perustoiminta|en=PET Basic Operations|
dc.contributor.organizationfi=sisätautioppi|en=Internal Medicine|
dc.contributor.organizationfi=kliininen fysiologia ja isotooppilääketiede|en=Clinical Physiology and Nuclear Medicine|
dc.contributor.organizationfi=PET tutkimus|en=PET Research|
dc.contributor.organizationfi=tyks, vsshp|en=tyks, vsshp|
dc.contributor.organizationfi=kliinisen laitoksen yhteiset|en=Department of Clinical Medicine|
dc.contributor.organizationfi=Turun PET-keskus|en=Turku PET Centre|
dc.contributor.organizationfi=PÄÄT Patologia ja oikeuslääketiede|en=PÄÄT Patologia ja oikeuslääketiede|
dc.contributor.organization-code2609810
dc.contributor.organization-code2609820
dc.contributor.organization-code2607300
dc.contributor.organization-code2607322
dc.contributor.organization-code2607318
dc.contributor.organization-code260981
dc.contributor.organization-code2607107
dc.converis.publication-id3640506
dc.converis.urlhttps://research.utu.fi/converis/portal/Publication/3640506
dc.identifier.jour-issn1475-2840
dc.okm.affiliatedauthorHellberg, Sanna
dc.okm.affiliatedauthorRoivainen, Anne
dc.okm.affiliatedauthorNuutila, Pirjo
dc.okm.affiliatedauthorMetsälä, Olli
dc.okm.affiliatedauthorLiljenbäck, Heidi
dc.okm.affiliatedauthorDataimport, tyks, vsshp
dc.okm.affiliatedauthorSaukko, Pekka
dc.okm.affiliatedauthorKnuuti, Juhani
dc.okm.affiliatedauthorSilvola, Johanna
dc.okm.affiliatedauthorViljanen, Tapio
dc.okm.affiliatedauthorKiugel, Max
dc.okm.affiliatedauthorSaraste, Antti
dc.okm.discipline3121 Sisätauditfi_FI
dc.okm.discipline3121 Internal medicineen_GB
dc.okm.internationalcopublicationnot an international co-publication
dc.okm.internationalityInternational publication
dc.okm.typeJournal article
dc.publisher.countryUnited Kingdomen_GB
dc.publisher.countryBritanniafi_FI
dc.publisher.country-codeGB
dc.relation.articlenumber26
dc.relation.doi10.1186/s12933-016-0340-6
dc.relation.ispartofjournalCardiovascular Diabetology
dc.year.issued2016


Aineistoon kuuluvat tiedostot

Thumbnail

Aineisto kuuluu seuraaviin kokoelmiin

Näytä suppeat kuvailutiedot